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Bacterial vaccines can reduce carriage rates. Colonization is usually a binary endpoint. Real time quantitative PCR
(qPCR) can quantify bacterial DNA in mucosal samples over a wide range. Using culture and single-gene species-
speciﬁc qPCRs for Streptococcus pneumoniae (lytA), Streptococcus pyogenes (ntpC), Moraxella catarrhalis (ompJ),
Haemophilus inﬂuenzae (hdp) and Staphylococcus aureus (nuc) and standard curves against log-phase reference strain
broth cultures we described frequency and peak density distributions of carriage in nasopharyngeal swabs from 161
healthy 2–4 y old children collected into STGG broth. In general, detection by qPCR and culture was consistent.
Discordance mostly occurred at lower detection thresholds of both methods, although PCR assays for S. pyogenes and
S. aureus were less sensitive. Density varied across 5-7 orders of magnitude for the 5 species with the abundant species
skewed toward high values (modes: S. pneumoniae log3-4, M. catarrhalis & H. inﬂuenzae log4-5 CFU/ml broth). Wide
ranges of bacterial DNA concentrations in healthy children carrying these bacteria could mean that different individuals
at different times vary greatly in infectiousness. Understanding the host, microbial and environmental determinants of
colonization density will permit more accurate prediction of vaccine effectiveness.
Introduction
The bacterial species Streptococcus pneumoniae, Streptococcus
pyogenes (group A streptococcus; GAS), Moraxella catarrhalis,
Haemophilus influenzae and Staphylococcus aureus are common
inhabitants of the mucosal surfaces of the human nasopharynx
(NP). Children routinely become colonised by these species
although the age distribution and the duration of colonization
varies.1-5 An example of this is colonization with S. pneumoniae,
rates of which increase in infancy, peak at 1–2 y of age and then
decline. GAS colonization on the other hand tend to be lower in
infants with gradual increases during the first decade of life.6 Sev-
eral capsular types of bacteria have been targeted by infant conju-
gate vaccine programmes which not only induce direct
protection in recipients but can also reduce carriage rates and so
transmission, thereby reducing the incidence of symptomatic
infection in the population at large.7 Thus improved methodolo-
gies for the study of colonization have the potential to improve
our understanding of the pathogenesis of disease, the mechanisms
of vaccine-induced herd protection, the potential for inter-species
interactions8 and ecological changes over time. Until recently
most studies have reported the detection of these organisms using
cultures from upper respiratory tract swabs.9 We recently
reported associations between both rhinitis symptoms and respi-
ratory viral infections and nasal bacterial density ascertained by
attributing semi-quantitative scores to numbers of colonies
visualised on bacterial culture plates10,11 but this approach only
allows resolution of differences in bacterial numbers over a nar-
row dynamic range. Improved and broadened quantitation of
bacterial carriage over a wider range would facilitate the study of
the biology of colonization and exploration of the determinants
of transmission. This can be achieved using real time PCR which
is now widely used in clinical practice and has great potential util-
ity in research studies by virtue of high levels of automation,
reproducibility, rapidity, sensitivity and specificity and low unit
staff-time and consumables costs.12,13 Whereas in clinical prac-
tice the capacity of PCR to detect bacterial DNA in the absence
of viable organisms, for example following antibiotic treat-
ment,14,15 may complicate interpretation of results, in studies of
bacterial colonization it can be an advantage as this footprint is
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of potential relevance. Finally, provided that appropriate species-
specific DNA sequences are targeted, PCR is less subject to the
potential biases and errors that can result during bacterial culture
and the phenotypic identification of resulting bacterial colonies.
In this study we employed qPCR monoplex assays using pre-
viously published gene targets for S. pneumoniae (lytA), GAS
(ntpC), M. catarrhalis (ompJ), H. influenzae (hdp) and S. aureus
(nuc) and serial dilutions of culture-quantified log-phase broth
cultures of reference strains of these species, permitting conver-
sion of qPCR cycle threshold (Ct) values into equivalent bacterial
concentrations measured in colony forming units (CFU)/ml of
culture broth. We validated these qPCR assays against
conventional agar plate cultures using a randomly selected subset
of 149 NP swab samples and then used them to describe the rates
and density distributions of nasal carriage of these 5 bacterial spe-
cies in 161 healthy 2–4 y old children each sampled up to 5 times
over the single winter season 2011-2012.
Results
Peak density distributions of bacterial carriage in young
healthy children
From 619 samples collected from 161 healthy children and
analyzed by qPCR, 79.5% were positive for S. pneumoniae, 4.4%
for GAS, 86.1% for
M. catarrhalis, 85.3% for H .
influenzae and 6.6% for S. aureus.
The respective percentages of
children in whom each of these
species were detected at least once
during the study were S. pneumo-
niae 97.5%, GAS 14.8%, M.
catarrhalis 98.1%, H. influenzae
98.7% and S. aureus 21.6%. For
each species, the result from each
colonised child which had the
highest density (peak value) was
selected for presentation and
these data are summarised as fre-
quency histograms in Figure 1.
The mode densities and the dis-
tributions around them look
quite distinct for the different
species with the 3 most frequently
carried species (S. pneumoniae, M.
catarrhalis and H. influenzae)
being, on average, present at
much higher density than the 2
less commonly carried species
(GAS and S. aureus).
Comparison of RT-PCR
against conventional cultures
In order to compare detection
with qPCR and conventional cul-
tures, 149 NP swab samples were
selected randomly and both cul-
tured and subjected to qPCR
analysis for S. pneumoniae, GAS,
M. catarrhalis, H. influenzae and
S. aureus (Table 1). For S. pneu-
moniae, M. catarrhalis and H.
influenzae, species for which the
large majority of samples were
positive, detection rates were
9.4–26.2% higher using qPCR
than culture and the large major-
ity of culture-positive samples
Figure 1. Bacterial peak density range. Peak winter time nasal density distributions of the 5 studied species in
pre-school children determined by qPCR. *:Horizontal lines indicate the range of densities that could be reli-
ably quantiﬁed by qPCR but not by semi-quantitative culture.
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also tested PCR-positive (Table 1). For GAS and S. aureus,
which were much less commonly found, detection rates were
lower by PCR than culture and culture-positive PCR-negative
samples were much more abundant relative to samples positive
by both methods. In all species tested, the mean density was
lower in samples only positive by either method alone than in
those positive by both.
PCR specificity panel
In every case, all 3 dilutions of all the bacterial strains in the spec-
ificity panel yielded appropriate positive or negative results by PCR.
Liquid cultures, dilutions and standard curves
Growth curves for the liquid cultures of the 5 reference strains
are shown in Figure 2. Dilutions yielded pure growths of the
respective species and appropriate colony counts for the 10-fold
dilutions across the 3.5 log range (3-4 dilutions) in which colo-
nies were both detectable and countable (data not shown).
The qPCR CT values for the heat inactivated 10-fold serial
dilutions from each species were used to plot standard curves
(twice each) against observed and calculated CFU/ml counts for
corresponding 10-fold dilutions of the liquid cultures (Fig. 3)
providing for each a conversion equation from one to the other,
taking into account the volumes used for culture and PCR. These
were used to generate CFU/ml broth equivalent values from
qPCR CT results from clinical samples processed in the same
assays. qPCR assays for S. aureus and GAS did not reliably detect
DNA from these standard strains from broth dilutions with low
density growth on agar plates (Fig. 3).
Discussion
In this study, we describe, for
the first time, the distributions of
peak colonization density of the
common culturable bacterial spe-
cies that inhabit the nasophar-
ynges of healthy young children.
We found somewhat higher rates
of carriage for pneumococci,
M. catarrhalis and H. influenzae
than previous reports.16-19 These
high rates by PCR may represent
DNA detection from organisms
previously present but no longer
viable and so undetectable by cul-
ture while relatively high rates by
culture in our population may
reflect high rates of wintertime
intercurrent viral infections and
intense transmission in these
young children in close contact
with one another in the day care
setting. Marked differences in the
relationship between coloniza-
tion frequency and density
between species are immediately
obvious (Fig. 1) which are likely
Table 1. Culture and qPCR results in 149 clinical NP swabs from 2–4 y old healthy children attending day care centers. Mean bacterial density in PCR positive
samples is shown in CFU/ml and in culture positive samples as means of density scores (DS)(0:0 1:1–5 CFU/ml broth 2:6-20 3:21-50 4:51-100 5:>100)(10).*:
One sample failed the GAS PCR and was omitted from the comparison
S. pneumoniae GAS* M. catarrhalis H. inﬂuenzae S. aureus
Culture C qPCRC 85 (57%) DS: 4.1 9 (6.1%) DS: 3.3 106 (71.1%) DS: 3.8 61 (40.9%) DS: 4.1 6 (4.0%) DS: 2.6
645 CFU/ml 825 CFU/ml 1330 CFU/ml 4840 CFU/ml 1495 CFU/ml
Culture C qPCR- 2 (1.3%) DS: 2.5 5 (3.4%) DS: 1.6 10 (6.7%) DS: 2.2 3 (2.0%) DS: 2.3 10 (6.7%) DS: 2.1
N/A N/A N/A N/A N/A
Culture - qPCRC 14 (9.4%) N/A 0 (0%) N/A 19 (12.8%) N/A 39 (26.2%) N/A 7 (4.7%) N/A
17 CFU/ml N/A 27 CFU/ml 205 CFU/ml 195 CFU/ml
Culture - qPCR- 48 (32.2%) N/A 134 (90.5%) N/A 14 (9.4%) N/A 46 (30.9%) N/A 126 (84.6%) N/A
N/A N/A N/A N/A N/A
Figure 2. Liquid cultures. Optical density at 600 nm (OD600) of the 5 species studied in liquid culture over
time. The black diamonds represent the points of harvest for quantiﬁcation experiments.
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to affect the efficiency with which they are transmitted within this
population and to other age groups. This analysis may therefore
more accurately predict spread than the simple rates of detection
reported in previous studies.20,21 Perhaps more importantly,
large differences in maximal colonization density are evident
between individual children. We propose that children with high
density colonization will transmit bacterial carriage more effi-
ciently than those with low density colonization. Given the evi-
dent importance of indirect effects on transmission, for the
effectiveness of bacterial vaccine programmes22-24 we propose
that future attempts to measure and predict such effects should
take account of the effect of
vaccination on colonization
density and not just its
frequency.
We used qPCR to detect
and quantify bacteria obtained
by nasopharyngeal swabbing
rather than conventional cul-
ture methods, principally
because of the wide range of
bacterial density over several
orders of magnitude25 that can
be measured simply and accu-
rately using this technique, but
also because of its expected
greater efficiency and lower
cost. However, with the meth-
odology we used, sensitivity
was poor for GAS and
S. aureus particularly in low
density samples. This may
have been due to inefficient
DNA extraction due to the
robust structure of the cell wall
of these organisms26-28 so that
more efficient lysis of samples
prior to DNA extraction might
increase the sensitivity of these
assays. Alternatively or addi-
tionally reducing the extrac-
tion eluate volume to increase
DNA concentration in samples
might do likewise. The effi-
ciency of these 2 qPCR assays
was also lower than the others,
leading to more than the
expected 3.3 cycle difference
of amplification signal between
successive 10-fold serial
dilutions (Fig. 3). Different
combinations of primer con-
centrations (50, 300 and
900 nM) were tested without
improvement (data not shown)
and the presence of inhibitors
could possibly explain this.29 Finally, since, in particular, experi-
ence with the ntpC gene target for PCR detection of GAS is still
very limited, it may be that other gene targets will provide better
assay performance. Development and validation of a multiplex
assay for the detection of these organisms will increase efficiency
and reduce costs even further although the potential pitfalls of
reduced sensitivity, accuracy and inter-assay competition30 will
need to be addressed before implementation. A cut-off level of
35 cycles is widely used in PCR assays and we have adopted that
in our work. More individually adapted levels of detection for
each primer set could possibly be adapted for increased accuracy.
Figure 3. qPCR standard curves. Standard curves (culture results (real and calculated) in CFU/ml broth vs cycle
threshold values). Each curve represents the average of the results of 3 PCR runs performed on a dilution series
of cultures of which 2 (both shown, solid line and dashed line) were done for each species. CT: Cycle Threshold.
CFU: colony forming units.
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The creation of standard curves which permit translation of
qPCR cycle threshold numbers for detection into absolute values
of bacterial density in CFU/ml makes the meaning of assay
results more accessible but also makes direct comparison between
studies of colonization density feasible even if different assays or
methods are used. Replicate dilution series done for each bacte-
rial species were closely concordant for M. catarrhalis and
H. influenzae and similar for S. pneumoniae but showed more
variation for the 3 less abundant species (Fig. 3).
Unsurprisingly, since PCR can detect DNA from non-viable
bacteria or bacterial fragments, although the large majority of the
149 randomly selected nasal swab samples generated concordant
positive or negative culture and qPCR results for all 6 bacterial spe-
cies, all apart from GAS yielded some that were PCR-positive but
culture-negative (Table 1). Of particular note, about one in 4
swabs were positive for H. influenzae by qPCR but not culture.
The lower detection rates of H. influenzae by culture may partly be
explained by failure reliably to observe the small colonies on agar
plate cultures and/or inaccurate results from biological identifica-
tion tests which are often ambiguous. For the rest, PCR-positive
culture-negative samples may represent samples with DNA but in
which viable bacteria are not present. Discrepancies could also be
due to genetic variation in primer or probe recognition sequences.
However, in the context of colonization studies, in contrast to clin-
ical diagnostics, if this represents detection of the footprint of pre-
vious carriage, these positive results are of interest and importance.
As might be expected, for all 5 species for which such samples were
found, they had substantially lower average of gene copies detected
than samples in which culture was also positive.
Among the 149 samples, there were also between 2 and 10
PCR-negative culture-positive samples for each species. Given
the observed low sensitivity of the GAS and S. aureus qPCR
assays, for these, such samples were to be expected. However,
since there is potential to detect even a single viable bacterium
manifest as a single colony from a 50-100 ml inoculum of broth
on agar, whereas even a highly efficient PCR reaction may need
multiple copies of a single gene in DNA extracted from 350 ml
of broth, in order reliably to detect their presence above back-
ground, small numbers of such discrepant results are also unsur-
prising. Once again, for all species tested, these samples had
lower average density by culture than samples positive both by
culture and PCR.
It will be of interest to compare these findings made in a UK
pre-school population with bacterial carriage density distribu-
tions in other places, in other age groups and in children who are
unwell.12 The other important question that arises is how,
exactly, colonization density equates to efficiency of transmission.
Is there a density below which it becomes very rare or, conversely,
is there a density above which there is no further increase in what
is effectively maximal transmission? Between these extremes, is
the relationship between density and successful transfer linear or,
more likely, otherwise? Finally, what other determinants of bacte-
rial phenotype also affect the capacity to transmit successfully
(so that 2 children with similar colonization density might have
very different infectiousness)? The interplay between respiratory
viral infections, upper respiratory tract-colonising bacteria and
host innate and specific anti-viral and anti-bacterial mucosal
immune responses will need to be elucidated more fully before
this ecosystem, its occasional punctuation by episodes of clini-
cally significant infectious illness and the ways it is affected by
both bacterial and viral vaccines can be properly understood. It is
important to find ways to answer such questions in order that
future studies of carriage, conducted to evaluate the indirect
effects of vaccines, can be interpreted correctly.
Subjects, Materials and Methods
Human subjects and sampling
The nasopharyngeal swab samples used were collected in clini-
cal studies of bacterial colonization in healthy 2–4 y old children
attending 9 day care centers in Bristol, UK between 2011 and
2013. Studies were approved by the National Research Ethics
Service – Central Bristol Committee and sponsored by the Uni-
versity of Bristol. The children were all fully vaccinated according
to the national UK schedule, were all attending the DCC and
had no signs of systemic illness at the time of sampling. Fine tip
pediatric nasopharyngeal swabs with rayon buds (Peel Pouch
DryswabTM Medical Wire & Equipment, Wiltshire, UK) were
inserted horizontally into the nasopharynx until resistance was
met then retracted with a slight twisting motion and tips were
inserted into 2 ml tubes containing 1.5 ml Skim milk-Tryptone-
Glucose-Glycerol (STGG) broth. Each child was sampled up to
5 times during a single winter season. Swabs were marked with a
random number from 1–700 using pre-printed non-consecutive
numbered labels, and stored at ¡80 C in boxes containing up
to 100 samples each.
Bacterial strains and plate cultures
Reference bacterial strains used for PCR assay development
and standardisation were: S. pneumoniae (ATCC 6303), GAS
(ATCC 19615), M. catarrhalis (ATCC 25240), H. influenzae
(ATCC 10211) and S. aureus (ATCC 25923), all from LGC
Standards Laboratories (Teddington, UK). M. catarrhalis and
S. aureus strains were cultured overnight for 16-18 hours on a
Columbia Blood Agar Base (CBA) supplemented plate with 5%
horse defibrinated blood (Oxoid, Basingstoke, UK). S. pneumo-
niae and GAS strains were cultured for 16-18 hours overnight on
a COBA plate (CBA plate with 0.25 mg colistin and 0.125 mg
oxalinic acid). H. influenzae was cultured for 16-18 hours over-
night on a bacitracin chocolate agar plate. All cultures were per-
formed at incubation temperature of 37C. 50 ml broth from
STGG clinical swab samples were likewise cultured on this set of
plates and under these conditions. For comparison of culture and
qPCR, given the high colonization rates, 150 samples were con-
sidered a representative sample size and they were randomly
selected by choosing the first 22 samples from each sample box
until 150 was reached. One sample was destroyed during the pro-
cess and was not replaced. A semi-quantitative score was allocated
for each cultured species from 0 through 5 (0 D no growth, 1 D
1-5 colonies per plate (thus 20-100 CFU/ml broth), 2 D 6-20,
3 D 21-50, 4 D 51-100 and 5 D >100).10
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Cultures in liquid medium
3-4 colonies of each standard strain from plate cultures were
used to inoculate 20 ml liquid media as follows: Todd-Hewitt
broth (Media services, School of Cellular and Molecular Medi-
cine, University of Bristol, UK) with 0.5% yeast extract (S. pneu-
moniae & GAS), Brain-Heart Infusion (Oxoid, Basingstoke,
UK) alone (S. aureus), with 10% defibrinated horse blood (M.
catarrhalis) or with 5% Fildes (haemin and nicotinamide adenine
dinucleotide from Oxoid, Basingstoke, UK) (H. influenzae) and
cultured at 37C in 5% CO2 static (S. pneumoniae & GAS) or at
50 (H. influenzae & S. aureus) or 100 (M. catarrhalis) rotations
per minute in 25 ml glass universals with the caps loosely fitted.
After 1 hour, and subsequently at regular intervals until the sta-
tionary phase was reached, optical density (OD) at 600 nm was
measured (Thermo Spectronic Genesys 6, Thermo Electron
Scientific Instruments LLC, WI, USA). When the OD600 was
0.4–0.6, 1 ml each broth culture was harvested and 10 ten-fold
serial dilutions prepared in STGG broth. 100 ml aliquots of each
dilution were plated out (as above) and aerobically incubated for
16-18 hours at 37C/5% CO2 prior to colony counts being per-
formed up to a maximum of 750 CFU per plate. For the pur-
poses of PCR, 350 ml aliquots of each liquid culture dilution
were also heat inactivated at 100C for 10 minutes using a digital
block heater (Grant Boekel BBD, Grant instruments, Cam-
bridge, UK). Successful inactivation was confirmed by appropri-
ate plate cultures for each species. For Sa, 90 minutes of heat
inactivation were necessary.
Preparation for and conduct of PCR assays
Target genes and corresponding primer selection were
informed by the published literature.31-36 Primers and probes
(Table 2) were assessed and optimised using Primer Express ver-
sion 3.0 (Life Technologies). The specificity of the primers for
the target species was assessed in silico using the National Center
for Biotechnology Information (NCBI) database and the Basic
Local Alignment Search Tool (BLAST).
Automated extraction of nucleic acids from samples was per-
formed (QIAsymphony QIAGEN, CA, USA) using DSP
Virus/Pathogen Mini Kit version 1 (QIAGEN, CA, USA). In
brief, after vortexing, 350-ml of each sample underwent bacterial
cell lysis, and total nucleic acids were captured on magnetic beads
and eluted into 110 ml elution buffer. DNA extract eluates were
dispensed into 96-well elution microtubes (QIAGEN, CA,
USA). After extraction the plates were sealed and stored frozen in
¡80C. Plates were thawed and centrifuged prior to PCR. A
QIAagility pipetting robot and software (QIAGEN, CA, USA)
was used to prepare PCR plates in reaction mixes containing
Applied Biosystems Fast Universal Master Mix (10 ml), primers
(300 nM), probe (100 nM) and DNA extracts (5 ml) - to a total
reaction volume of 20 ml.
The Applied Biosystems ViiA 7TM real time PCR system (Life
Technologies, USA) was used for amplification and detection of
DNA using MicroAmp optical 384-well reaction plates (Life
Technologies, USA). Reaction conditions for DNA amplification
were a 20 second hold stage at 95C followed by 50 cycles of
95C for 3 seconds and 60C for 1 min. Samples with CT values
 35 were considered positives. ViiATM 7 Software version 1.2.2
(Life Technologies, USA) was used for data analysis.
The bacteriophage T4 was used as an internal amplification
control (successful DNA extraction and absence of PCR inhibi-
tion) in all PCR assays. Two dilutions of DNA extracts of each
target reference strain were used as positive controls and DNA
extracts of STGG broth and molecular grade water as negative
reagent controls. A specificity panel (Table 3) containing DNA
extracts of three dilutions (2-, 4- and 6-fold dilution with STGG
broth of pure culture isolates) of heat-inactivated cultures of the
same and other species was also tested.
Table 2. Target genes and primer and probe sequences used for qPCR assays. BHQ: Black Hole Quencher. *:Primer design from this study
Organism Gene Forward Primer Sequence 50 - 30 Reverse Primer Sequence 50 - 30 [Dye]ProbeSequence 50 - 30
S. pneumoniae31 lytA ACGCAATCTAGCAGATGAAGCA TCGTGCGTTTTAATTCCAGCT [Cy5]GCCGAAAACGCTTGATACAGGGAG[BHQ2]
S. pyogenes* ntpC TGCACCAGTCAGTCTATCACC AGCGATAGGTCTTGGTTAGCTC [6FAM]TGACGATCTCAACGATTTGGATCGG[BHQ1]
M. catarrhalis36 ompJ CAGCCTAGCAGGCGGTGTT TTGCTTCAACGCCCACATT [VIC]TTGGCTTTAAACCATTAGC[MGB]
H. inﬂuenzae* hdp TTGGCCCAGGTTGGTATATG TTACGCACGGTGTAAGGATG [6FAM]CACTCCGTTGGTAAAAGAACTTGCACA[BHQ1]
S. aureus33 nuc GTTGCTTAGTGTTAACTTTAGTTGTA AATGTCGCAGGTTCTTTATGTAATTT [6FAM]AAGTCTAAGTAGCTCAGCAAATGCA[BHQ1]
Table 3. Bacterial strains used to prepare a panel of speciﬁcity controls
Organism Strain
Streptococcus agalactiae ATCC 12403
Streptococcus mitis NCTC 10712
Staphylococcus epidermidis NCTC 11047
Enterococcus faecalis JH2–2
Streptococcus oralis NCTC 11427
Staphylococcus aureus ATCC 25923
Streptococcus pneumoniae ATCC 6303
Streptococcus pyogenes ATCC BAA-1064
Streptococcus pseudopneumoniae ATCC BAA-960
Streptococcus parasanguinis ATCC 15912
Escherichia coli ATCC 25922
Neisseria lactamica From other carriage studies
Neisseria gonorrhoea ATCC 31426
Pseudomonas aeruginosa From other carriage studies
Haemophilus parainﬂuenzae From other carriage studies
Neisseria meningitidis A ATCC 53417
Neisseria meningitidis B ATCC BAA-335
Neisseria meningitidis C ATCC 53414
Neisseria meningitidis D ATCC 53419
Neisseria meningitidis W135 ATCC 35559
Neisseria meningitidis X ATCC 35560
Neisseria meningitidis Y ATCC 35561
Klebsiella pneumoniae From other carriage studies
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